Harbor Human Capital Factor Unconstrained ETF
HAPY
HAPY was delisted on the 11th of September, 2025.
3 hedge funds and large institutions have $350K invested in Harbor Human Capital Factor Unconstrained ETF in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
11% more capital invested
Capital invested by funds: $317K → $350K (+$33.3K)
0.1% more ownership
Funds ownership: 2.58% → 2.67% (+0.1%)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
New York
|
+$12.8K |
| 2 |
Morgan Stanley
New York
|
+$22 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$657 |
HAPY Hedge Fund Activity: Q1 2024 in Review
3 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Harbor Human Capital Factor Unconstrained ETF (HAPY) for Q1 2024, worth a combined $350K — up 11% from $317K a quarter earlier.
Fund positioning in HAPY was balanced in Q1 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was GTS Securities, adding an estimated $12.8K. The largest seller was UBS Group, exiting entirely with an estimated $657 sold.
- 3 institutional investors held Harbor Human Capital Factor Unconstrained ETF (HAPY) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $350K of Harbor Human Capital Factor Unconstrained ETF stock for Q1 2024, up 11% quarter-over-quarter.
- 1 fund opened new Harbor Human Capital Factor Unconstrained ETF positions in Q1 2024 and 1 closed out, a net change of 0 holders.
- The largest Harbor Human Capital Factor Unconstrained ETF buyer in Q1 2024 was GTS Securities, an estimated $12.8K added.
- The largest Harbor Human Capital Factor Unconstrained ETF seller in Q1 2024 was UBS Group, an estimated $657 sold.
Based on aggregated 13F filings for Q1 2024.